Skip to content

GI Cancers

US Focus Meeting 2026

📍 Estancia La Jolla Hotel, 9700 N Torrey Pines Rd, La Jolla, CA 92037

🗓️ July 24-25, 2026

Last Year's Highlights

Dear Colleagues and Friends,

We are delighted to extend our warmest invitation to the GI Cancers Focus Meeting 2026, to be held at on July 24 - 25, 2026.

Centered around the theme “Updating Knowledge & Clinical Practice in 2026” this meeting provides pivotal collaboration aimed at advancing GI Cancers research and patient treatment.

This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.

 

Chairs of Cell Therapy & Bispecifics US Focus Meeting 2026:

Tanios-Saab

Tanion Bekaii-Saab, MD
Mayo Clinic, Phoenix, AZ

Eileen-OReilly

Eileen M. O’Reilly , MD
Memorial Sloan Kettering Cancer Center, New York City, NY

Supporters to be announced...
Interested in supporting this meeting? Get in contact:
alex.worthington@md-education.com

Agenda & Faculty

July 24, 2026 | Day 1

07:00 AM
Registration Opens
08:00 AM
Industry Supported Independent Expert Discussion
08:45 AM
Coffee Break

Session I: Pancreas Cancer
Moderated by:

Tanios-Saab

Tanios Bekaii-Saab, MD
Mayo Clinic, Phoenix, AZ


09:05 AM
First-line Chemotherapeutic Options in mPDAC
Zev-Wainberg
Zev Wainberg, MD
UCLA Health, Los Angeles, CA
09:25 AM
RAS Directed-Therapies in mPDAC
Eileen-OReilly
Eileen M. O’Reilly, MD
Memorial Sloan Kettering Cancer Center, New York City, NY
09:45 AM
Targeted (Excluding RAS Directed) Therapies in mPDAC
Michael-Pishvaian
Michael Pishvaian, MD
Johns Hopkins Medicine, Baltimore, MD
10:05 AM
Panel Discussion
10:25 AM
Coffee Break

Session II: Biliary Tract Cancers (BTC)
Moderated by:

Mitesh-Borad

Mitesh Borad, MD
Mayo Clinic, Phoenix, AZ

10:45 AM
Targeted Therapies in Advanced BTC
Tanios-Saab
Tanios Bekaii-Saab, MD
Mayo Clinic, Phoenix, AZ
11:05 AM
1L Options on Advanced BTC
Katie-Kelley
Katie Kelley, MD
UCSF Health, San Francisco, CA
11:25 AM
Emerging Treatment Landscape in Early-stage BTC
Lipika-Goyal
Lipika Goyal, MD
Stanford Medicine, CA
11:45 AM
Panel Discussion
12:05 PM
Lunch Break + Faculty and Fellow Photo
12:55 PM
Industry Supported Independent Expert Discussion

Session III: Hepatocellular Cancer (HCC)
Moderated by:

Tanios-Saab

Tanios Bekaii-Saab, MD
Mayo Clinic, Phoenix, AZ

1:40 PM
Navigating First-line Treatment Options in HCC
Anthony-Khoueiry
Anthony El-Khoueiry, MD
USC Norris Comprehensive Cancer Center, Los Angeles, CA
2:00 PM
Second-line Options in HCC in the Era of Immunotherapy
Ghassan-AbouAlfa
Ghassan Abou-Alfa, MD
Memorial Sloan Kettering Cancer Center, New York, NY
2:20 PM
Integrating Systemic Therapy in Early-stage HCC
Richard-Finn
Richard Finn, MD
UCLA, Santa Monica, CA
2:40 PM
Panel Discussion
3:00 PM
Coffee Break
3:20 PM
Industry Supported Independent Expert Discussion

Session IV: Neuroendocrine Tumors (NET)
Moderated by:

Mohamad-Sonbol

Mohamad Bassam Sonbol, MD
Mayo Clinic, Phoenix, AZ

4:05 PM
The Role of Peptide Receptor Radionuclide Therapy (PRRT) in NET
Lisa-Bodei
Lisa Bodei, MD
Memorial Sloan Kettering Cancer Center, New York, NY
4:25 PM
The Role of TKIs in NET
Jennifer-Chan
Jennifer Chan, MD
Dana-Farber Cancer Institute, Boston, MA
4:45 PM
Systemic Therapy Opportunities in Earlystage NET
Thorvardur-Halfdanarson
Thorvardur Halfdanerson, MD
Mayo Clinic, Rochester, MN
5:05 PM
Panel Discussion
5:25 PM
Adjourn

Agenda & Faculty

July 25, 2026 | Day 2

07:00 AM
Registration Opens
08:00 AM
Industry Supported Independent Expert Discussion
08:45 AM
Coffee Break

Session V: Esophagogastric Cancer (EGC)
Moderated by:

ElRayes-Bassel

Bassel El-Reyes, MD
O'Neal Comprehensive Cancer Center UAB, Birmingham, AL


9:05 AM
Expanding the Role of Targeted Therapies in Advanced ECG
Samuel-Klempner
Samuel Klempner, MD
Massachusetts General Hospital, Boston, MA
9:25 AM
Immunotherapy Options in Advanced ECG: Who is a Candidate?
Nataliya-Uboha
Nataliya Uboha, MD
UW Health, Madison, WI
9:45 AM
Perioperative Strategies in EGC: An Evolving Landscape
Mohamad-Sonbol
Mohamad Bassam Sonbol, MD
Mayo Clinic, Phoenix, AZ
10:05 AM
Panel Discussion
10:25 AM
Coffee Break

Session VI: Metastatic Colorectal Cancer (mCRC)
Moderated by:

Mohamad-Sonbol

Christopher Lieu, MD
University of Colorado Anschutz Medical Campus, Aurora, CO

10:45 AM
Understanding the Role of HER2 in mCRC and Overcoming Mechanisms of Resistance
John-Strickler
John Strickler, MD
Duke University, Durham, NC
11:05 AM
Targeting the MAPK Pathway in mCRC
Rona-Yaeger
Rona Yaeger, MD
Memorial Sloan Kettering Cancer Center, New York, NY
11:25 AM
The Potential for Immunotherapy in MSS mCRC
Kristen-Ciombor
Kristen Ciombor, MD
Vanderbilt University Medical Center, Nashville, TN
11:45 AM
Panel Discussion
12:05 PM
Lunch Break
12:55 PM
Industry Supported Independent Expert Discussion

Session VII: Early-Stage CRC
Moderated by:

Cathy-Eng

Cathy Eng, MD
Vanderbilt University Medical Center, Nashville, TN

1:40 PM
MSI-H Colon and Rectal Cancers and Emerging Options
Michael-Overman
Michael Overman, MD
MD Anderson Cancer Center, Houston, TX
2:00 PM
Moving Away from Trimodality Therapy for MSS Rectal Cancer
Joshua-Smith
Joshua Smith, MD
MD Anderson Cancer Center, Houston, TX
2:20 PM
The Role of MRD in Early Stage CRC
ElRayes-Bassel
Bassel El-Reyes, MD
O’Neal Comprehensive Cancer Center UAB, Birmingham, AL
2:40 PM
Panel Discussion
3:00 PM
Coffee Break
3:20 PM
Industry Supported Independent Expert Discussion

Session VIII:Managing “The Rare"
Moderated by:

Eileen-OReilly

Eileen M. O’Reilly, MD
Memorial Sloan Kettering Cancer Center, New York City, NY

4:05 PM
Emerging Strategies in the Treatment of GIST
Jonathan-Trent
Jonathan Trent, MD
University of Miami Miller School of Medicine, Miami, FL
4:25 PM
Managing Rare Fusions (NTRK, RET and others)
Mitesh-Borad
Mitesh Borad, MD
Mayo Clinic, Phoenix, AZ
4:45 PM
Managing Rare Fusions (NTRK, RET and others)
Cathy-Eng
Cathy Eng, MD
Vanderbilt University Medical Center, Nashville, TN
5:05 PM
Panel Discussion
5:25 PM
Adjourn

Alex Worthington
Project Manager

How long has Alex Worthington been in the business?

Alex Worthington has been with MD Education since 2024.

About Charlotte Pilling

As Project Manager, I work to ensure the smooth running of events, assisting in the search process, outreach, organization, and the maintenance of any event. Having a diverse career background working around the world, I pride myself on networking and creating positive relationships seamlessly with all attendees.

Alex-Worthington 2